ERBB2 and gastric cancer: The NCCN Gastric Cancer Guidelines recommend the addition of trastuzumab to a fluoropyrimidine- and platinum-based chemotherapy backbone as the preferred first-line regimen, with HER2 testing required prior to treatment initiation [30].